These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36964913)
21. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement. Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J; World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388 [TBL] [Abstract][Full Text] [Related]
22. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336 [TBL] [Abstract][Full Text] [Related]
23. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center. Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914 [TBL] [Abstract][Full Text] [Related]
24. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192 [TBL] [Abstract][Full Text] [Related]
25. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy. Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953 [TBL] [Abstract][Full Text] [Related]
26. Micromedullary thyroid cancer: how micro is truly micro? Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813 [TBL] [Abstract][Full Text] [Related]
27. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience. Samulski TD; Livolsi VA; Montone K; Baloch Z Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099 [TBL] [Abstract][Full Text] [Related]
28. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910 [TBL] [Abstract][Full Text] [Related]
29. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. Gimm O; Ukkat J; Dralle H World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929 [TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease. Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930 [TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Yen TW; Shapiro SE; Gagel RF; Sherman SI; Lee JE; Evans DB Surgery; 2003 Dec; 134(6):890-9; discussion 899-901. PubMed ID: 14668720 [TBL] [Abstract][Full Text] [Related]
33. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study. Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824 [TBL] [Abstract][Full Text] [Related]
35. Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule. Fukushima M; Ito Y; Hirokawa M; Miya A; Kobayashi K; Akasu H; Shimizu K; Miyauchi A World J Surg; 2009 May; 33(5):963-8. PubMed ID: 19198929 [TBL] [Abstract][Full Text] [Related]
36. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study. Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525 [TBL] [Abstract][Full Text] [Related]
37. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned. Machens A; Lorenz K; Weber F; Dralle H J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951 [TBL] [Abstract][Full Text] [Related]
38. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening. Torresan F; Mian C; Cavedon E; Iacobone M Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267 [TBL] [Abstract][Full Text] [Related]
39. [Decision making in postoperative incidentally found small C-cell-carcinoma]. Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440 [TBL] [Abstract][Full Text] [Related]
40. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays? Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]